Form 4 for TECH Bio-Techne
Accepted 2023-10-30 00:00:00 ET · period of report 2023-10-26 · accession 0001062993-23-019852 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-30 | 2023-10-26 | TECH | STEER RANDOLPH C | Dir | A - Grant | $0.00 | +1,625 | 24.2K | +7% | $0 |
| D | 2023-10-30 | 2023-10-26 | TECH | STEER RANDOLPH C | Dir | A - Grant | $0.00 | +3,937 | 3,937 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-26 | A | A | 1,625 | $0.00 | 24,201 | D | — | — | |
| 2 | Derivative | Stock Options (Right to Buy) | 2023-10-26 | A | A | 3,937 | $0.00 | 3,937 | D | $61.51 · — to 2033-10-26 | 3,937 Common Stock | (F1) The option vests on the earlier of the one year anniversary of the grant date (10/26/23) or the date of Bio-Techne's 2024 annual meeting of shareholders. |